Boston Scientific Corp

NYSE:BSXHealthcareCBOE:SPESGSTOXX:EDD24BP

$45.05+1.49%At closeAt close · Tue 20 Oct · ≈ AED 165.45 · Market cap $65.29B · Next earnings Wed 28 Oct · Extended $45.02 −0.07%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	56.2%	62.8%	60.8%	62.0%	61.3%	69.0%	—	—
Operating margin	6.1%	16.2%	14.4%	15.3%	15.7%	19.8%	19.8%	+0.0 pts
Net margin	−0.8%	8.7%	5.5%	11.2%	11.1%	14.4%	14.4%	+0.0 pts
EBITDA margin	15.2%	21.2%	21.6%	24.2%	23.5%	25.4%	—	—
Return on equity	−0.5%	6.3%	4.0%	8.3%	8.5%	11.9%	11.8%	−0.1 pts
Return on assets	−0.3%	3.2%	2.1%	4.5%	4.7%	6.6%	6.6%	+0.0 pts
Return on capital employed	2.2%	6.9%	6.4%	7.2%	8.0%	10.4%	—	—
Debt / equity	0.6×	0.6×	0.5×	0.5×	0.5×	0.5×	0.5×	−1.0%
Debt / assets	31.0%	29.3%	28.6%	27.0%	28.3%	28.4%	—	—
Interest coverage	1.3×	5.5×	3.9×	8.0×	6.8×	11.4×	—	—
Current ratio	1.8×	1.5×	1.5×	1.3×	1.1×	1.6×	1.6×	+0.0%
Quick ratio	1.5×	1.1×	1.0×	0.8×	0.6×	1.1×	—	—
Cash ratio	0.5×	0.5×	0.2×	0.2×	0.1×	0.4×	0.4×	+0.0%
Asset turnover	0.3×	0.4×	0.4×	0.4×	0.4×	0.5×	—	—
Inventory turnover	3.2×	2.7×	2.7×	2.2×	2.3×	2.1×	—	—
Receivables turnover	6.5×	6.7×	6.4×	6.4×	6.5×	6.9×	—	—
Dividend payout	−34.1%	5.3%	7.9%	1.8%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.